{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:22:13Z","timestamp":1776824533111,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,7]],"date-time":"2017-05-07T00:00:00Z","timestamp":1494115200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Steven and Alexandra Cohen foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.04.079","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T22:00:48Z","timestamp":1493935248000},"page":"3178-3185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development"],"prefix":"10.1016","volume":"35","author":[{"given":"Jerilyn R.","family":"Izac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Lee D.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Earnhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2017.04.079_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pt.2010.01.006","article-title":"Lyme borreliosis in dogs and humans in the USA","volume":"26","author":"Little","year":"2010","journal-title":"Trends Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.04.079_b0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/01652176.2002.9695196","article-title":"Borrelia burgdorferi infections with special reference to horses. A review","volume":"27","author":"Butler","year":"2005","journal-title":"Vet Q"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.04.079_b0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.prevetmed.2012.07.002","article-title":"Dogs and horses with antibodies to outer-surface protein C as on-time sentinels for ticks infected with Borrelia burgdorferi in New York State in 2011","volume":"107","author":"Wagner","year":"2012","journal-title":"Prev Vet Med"},{"issue":"4","key":"10.1016\/j.vaccine.2017.04.079_b0020","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jvim.13973","article-title":"Seroprevalence of Borrelia burgdorferi in Horses Presented for Coggins Testing in Southwest Virginia and Change in Positive Test Results Approximately 1 Year Later","volume":"30","author":"Funk","year":"2016","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3347\/kjp.2016.54.1.97","article-title":"Serological Detection of Borrelia burgdorferi among Horses in Korea","volume":"54","author":"Lee","year":"2016","journal-title":"Korean J Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.079_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S1984-29612014040","article-title":"Evidence of Borrelia in wild and domestic mammals from the state of Minas Gerais, Brazil","volume":"23","author":"Montandon","year":"2015","journal-title":"Rev Bras Parasitol Vet"},{"issue":"6","key":"10.1016\/j.vaccine.2017.04.079_b0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1292\/jvms.12-0449","article-title":"Prevalence of tick borne pathogens in horses from Italy","volume":"75","author":"Laus","year":"2013","journal-title":"J Vet Med Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2017.04.079_b0040","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1089\/vbz.2010.0254","article-title":"Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania","volume":"11","author":"Kiss","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/000992280204100107","article-title":"Parental knowledge of and attitudes toward LYMErix (recombinant Osp\u2013a lyme vaccine)","volume":"41","author":"Barone","year":"2002","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.04.079_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2958.1989.tb00194.x","article-title":"Molecular analysis of the linear plasmid encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorferi","volume":"3","author":"Bergstr\u00f6m","year":"1989","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2017.04.079_b0060","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/JCM.37.7.2137-2141.1999","article-title":"Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature","volume":"37","author":"Obonyo","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2017.04.079_b0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1286-4579(01)01435-6","article-title":"Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis","volume":"3","author":"Gilmore","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2017.04.079_b0070","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1046\/j.1365-2958.2003.03537.x","article-title":"Transcriptional regulation of the ospAB and ospC promoters from Borrelia burgdorferi","volume":"48","author":"Alverson","year":"2003","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.04.079_b0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/153036603768395825","article-title":"Dynamic changes in Borrelia burgdorferi populations in Ixodes scapularis (Acari: Ixodidae) during transmission: studies at the mRNA level","volume":"3","author":"Piesman","year":"2003","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2017.04.079_b0080","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JB.00085-08","article-title":"Reciprocal expression of ospA and ospC in single cells of Borrelia burgdorferi","volume":"190","author":"Srivastava","year":"2008","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.183.1.271","article-title":"Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine","volume":"183","author":"de Silva","year":"1996","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/153036601750137705","article-title":"OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks","volume":"1","author":"Tsao","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.04.079_b0095","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1073\/pnas.89.12.5418","article-title":"Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice","volume":"89","author":"Fikrig","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.04.079_b0100","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/IAI.67.1.173-181.1999","article-title":"The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis","volume":"67","author":"Akin","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.079_b0110","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1073\/pnas.90.9.4092","article-title":"Evasion of protective immunity bu Borrelia burgdorferi by truncation of outer surface protein B","volume":"90","author":"Fikrig","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.04.079_b0115","series-title":"Borrelia: molecular biology, host interaction and pathogenesis","first-page":"467","article-title":"Lyme disease vaccines","author":"Marconi","year":"2010"},{"key":"10.1016\/j.vaccine.2017.04.079_b0120","series-title":"Vaccines for biodefense and emerging and neglected diseases","first-page":"1032","article-title":"Lyme disease","author":"Earnhart","year":"2009"},{"issue":"3","key":"10.1016\/j.vaccine.2017.04.079_b0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2006.07.052","article-title":"Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains","volume":"25","author":"Earnhart","year":"2007","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2017.04.079_b0130","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1016\/j.vaccine.2006.12.051","article-title":"Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens","volume":"25","author":"Earnhart","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.04.079_b0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/hv.4661","article-title":"An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences","volume":"3","author":"Earnhart","year":"2007","journal-title":"Hum Vaccin"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2017.04.079_b0140","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0264-410X(00)00520-X","article-title":"The prevention of Lyme disease with vaccine","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0891-5520(05)70047-7","article-title":"Vaccination as a modality to prevent Lyme disease. A status report","volume":"13","author":"Wormser","year":"1999","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.vaccine.2017.04.079_b0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF02962365","article-title":"Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State","volume":"26","author":"Wormser","year":"1998","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0155","first-page":"38","article-title":"Death of a vaccine\u2013the fall of LYMErix","volume":"37","author":"Zundorf","year":"2008","journal-title":"Pharm Unserer Zeit"},{"issue":"9","key":"10.1016\/j.vaccine.2017.04.079_b0160","first-page":"570","article-title":"Lyme disease vaccine\u2013LYMErix","volume":"63","author":"Parenti","year":"1999","journal-title":"Conn Med"},{"key":"10.1016\/j.vaccine.2017.04.079_b0165","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2017.04.079_b0170","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/IAI.61.7.2774-2779.1993","article-title":"Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"Kalish","year":"1993","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2017.04.079_b0175","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1073\/pnas.0305680101","article-title":"An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope","volume":"101","author":"Willett","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2017.04.079_b0180","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/CVI.00406-14","article-title":"A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato","volume":"21","author":"Wressnigg","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.04.079_b0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1586\/14760584.2013.824704","article-title":"A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I\/II studies","volume":"12","author":"Barrett","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2017.04.079_b0190","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CVI.00409-06","article-title":"OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine","volume":"14","author":"Earnhart","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2017.04.079_b0195","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/CVI.00099-06","article-title":"Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development","volume":"13","author":"Buckles","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2017.04.079_b0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1042\/bst0310108","article-title":"Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi","volume":"31","author":"Schwan","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"10.1016\/j.vaccine.2017.04.079_b0205","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/IAI.01950-05","article-title":"Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection","volume":"74","author":"Tilly","year":"2006","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.079_b0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004300050083","article-title":"Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans","volume":"187","author":"Fingerle","year":"1998","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.079_b0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/IAI.68.1.411-414.2000","article-title":"Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice","volume":"68","author":"Gilmore","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.079_b0220","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/IAI.65.11.4661-4667.1997","article-title":"Borrelia burgdorferi strain-specific OspC mediated immunity in mice","volume":"65","author":"Bockenstedt","year":"1997","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2017.04.079_b0225","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/IAI.01542-15","article-title":"The Treponema denticola FhbB Protein Is a Dominant Early Antigen That Elicits FhbB Variant-Specific Antibodies That Block Factor H Binding and Cleavage by Dentilisin","volume":"84","author":"Miller","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.079_b0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tvjl.2016.11.001","article-title":"Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development","volume":"218","author":"Oliver","year":"2016","journal-title":"Vet J"},{"issue":"11","key":"10.1016\/j.vaccine.2017.04.079_b0235","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1128\/IAI.00410-08","article-title":"Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector","volume":"76","author":"Battisti","year":"2008","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2017.04.079_b0240","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CVI.05004-11","article-title":"Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate","volume":"18","author":"Earnhart","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.079_b0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tvjl.2013.07.019","article-title":"Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design","volume":"198","author":"Rhodes","year":"2013","journal-title":"Vet J"},{"issue":"6","key":"10.1016\/j.vaccine.2017.04.079_b0250","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1128\/IAI.63.6.2221-2227.1995","article-title":"Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi","volume":"63","author":"Ma","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.04.079_b0255","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/IAI.62.5.2037-2045.1994","article-title":"A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OpsB protein","volume":"62","author":"Sadziene","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2017.04.079_b0260","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1110\/ps.9.5.1002","article-title":"Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping","volume":"9","author":"Legros","year":"2000","journal-title":"Protein Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.079_b0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jmb.2005.04.066","article-title":"Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA","volume":"350","author":"Koide","year":"2005","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.079_b0270","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4049\/jimmunol.151.2.900","article-title":"Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice","volume":"151","author":"Bockenstedt","year":"1993","journal-title":"J Immunol"},{"issue":"6660","key":"10.1016\/j.vaccine.2017.04.079_b0275","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/37551","article-title":"Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi","volume":"390","author":"Fraser","year":"1997","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vaccine.2017.04.079_b0280","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/JCM.37.12.3965-3970.1999","article-title":"Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity","volume":"37","author":"Marconi","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.04.079_b0285","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/JCM.30.11.2830-2834.1992","article-title":"Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis","volume":"30","author":"Marconi","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"15","key":"10.1016\/j.vaccine.2017.04.079_b0290","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/jb.176.15.4572-4582.1994","article-title":"Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange","volume":"176","author":"Marconi","year":"1994","journal-title":"J Bacteriol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.04.079_b0295","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/JCM.41.11.5059-5065.2003","article-title":"Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness","volume":"41","author":"Lagal","year":"2003","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:15:56Z","timestamp":1692792956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":59,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17305807"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}